Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Biogen inc. source : Www.biospace.com save search
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ABCL | $3.92 0.0% 770K
|
|
| O: 5.03%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.03%
H: 3.1%
C: 3.03%
neurological
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Published: 2024-02-14 (Crawled : 15:00) - biospace.com/
SAGE | News | $13.03 3.66% 3.53% 1.8M
|
Health Technology
|
| O: 9.69%
H: 8.48%
C: 1.98%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: -2.76%
business year pipeline therapeutics financial results
Alcyone Therapeutics Announces First Patient Implanted in PIERRE IDE Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)
Published: 2024-01-03 (Crawled : 18:00) - biospace.com/
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -0.72%
H: 0.55%
C: -1.71%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.21%
H: 0.01%
C: -1.8%
spinraza first system therapeutics study
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
Published: 2023-11-07 (Crawled : 15:00) - biospace.com/
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
SMMT A | $3.51 -1.68% -1.71% 1.2M
|
Health Technology
|
| O: -0.46%
H: 6.68%
C: -11.75%
PLSE | $7.37 -1.34% -1.36% 150K
|
Health Technology
|
| O: 0.39%
H: 6.43%
C: 1.92%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.82%
H: 0.73%
C: -0.4%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 1.06%
H: 2.42%
C: 0.76%
therapeutics financial results
Octave® Bioscience, Inc. Announces Real-World Study Using its Multimodal Precision Care Solution for Multiple Sclerosis Patient Management
Published: 2023-09-06 (Crawled : 18:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: -1.03%
octave management solution sclerosis care study
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Published: 2023-08-07 (Crawled : 12:00) - biospace.com/
SAGE | News | $13.03 3.66% 3.53% 1.8M
|
Health Technology
|
| O: -46.84%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -2.22%
H: 3.34%
C: 3.14%
business pipeline therapeutics financial results
STRM.BIO Appoints Independent Director Minnie Mildwoff, to its Board of Directors
Published: 2023-07-24 (Crawled : 14:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.07%
H: 0.68%
C: 0.17%
THE AHEAD STUDY IS TESTING LECANEMAB AT THE STAGE OF PRECLINICAL ALZHEIMER'S DISEASE
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.56%
H: 0.19%
C: -0.06%
disease lecanemab preclinical alzheimer's study
Alcyone Therapeutics Receives FDA IDE Approval to Initiate Clinical Study of the ThecaFlex DRxTM System for Administration of SPINRAZA® (nusinersen)
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: 0.08%
H: 1.3%
C: 0.59%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.12%
H: 0.56%
C: 0.37%
spinraza fda approval system therapeutics study
AI Proteins Announces the Formation of a Scientific Advisory Board Made up of Experts in Biotech and FDA Drug Approval
Published: 2023-05-31 (Crawled : 17:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.3%
C: -0.76%
fda drug biotech approval
Legend Biotech Reports First Quarter 2023 Results and Recent Highlights
Published: 2023-05-18 (Crawled : 13:00) - biospace.com/
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: -1.22%
H: 1.18%
C: -2.19%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.13%
H: 0.12%
C: -0.13%
biotech results
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
Published: 2023-05-05 (Crawled : 09:00) - biospace.com/
CRSP M | $56.14 1.04% 1.03% 1.7M
|
Health Technology
|
| O: 1.88%
H: 6.97%
C: 3.09%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.08%
H: 1.89%
C: 1.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.66%
west pharmaceuticals research therapy
PureTech Announces Annual Results for Year Ended December 31, 2022
Published: 2023-04-28 (Crawled : 13:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: -2.66%
H: 0.0%
C: 0.0%
AKLI | $0.238 11.63% 10.42% 200K
|
|
| O: 0.0%
H: 4.85%
C: 2.91%
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: 1.28%
H: 0.0%
C: 0.0%
VOR | $1.685 -2.6% -2.67% 150K
|
|
| O: 0.23%
H: 6.24%
C: 0.91%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: -0.42%
H: 4.27%
C: 3.81%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.06%
H: 3.94%
C: 3.51%
year results
Muscular Dystrophy Association Celebrates FDA Approval of Biogen’s Qalsody for Treatment of SOD1-ALS
Published: 2023-04-25 (Crawled : 21:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.68%
H: 1.01%
C: -2.97%
fda association approval treatment
Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.68%
H: 1.01%
C: -2.97%
pipeline
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: -3.53%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.68%
H: 1.01%
C: -2.97%
pipeline
Biogen Exercises Option with Denali to Develop and Commercialize Antibody Transport Vehicle Program Targeting Amyloid
Published: 2023-04-12 (Crawled : 14:00) - biospace.com/
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: 6.96%
H: 0.0%
C: -5.37%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.31%
H: 0.89%
C: 0.43%
antibody program
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Published: 2023-04-10 (Crawled : 12:00) - biospace.com/
TCRX | News 0 d | $6.9 2.22% 2.17% 250K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 2.21%
C: -3.98%
RARE | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: -0.91%
H: 0.38%
C: -4.84%
EDIT | $5.56 -0.89% -0.9% 1.7M
|
Health Technology
|
| O: -1.01%
H: 0.29%
C: -3.21%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.49%
H: 0.09%
C: -0.89%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: -2.16%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: -2.05%
therapeutics
New Data Presented at AD/PD™ 2023 Show Biogen’s BIIB080 (MAPT ASO) Substantially Reduced Tau Protein Levels in Patients with Early-stage Alzheimer’s Disease
Published: 2023-03-29 (Crawled : 17:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.32%
H: 1.29%
C: 1.07%
biib080 disease alzheimer’s protein tau show
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALSSOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United States
Published: 2023-03-23 (Crawled : 07:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.62%
H: 1.75%
C: 0.89%
fda rare disease genetic update meeting
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.